Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Breast Cancer Patients
NCT ID: NCT03046238
Last Updated: 2017-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
60 participants
INTERVENTIONAL
2017-02-02
2017-04-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block
NCT03063073
Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery
NCT05361837
Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block
NCT06300099
Comparison of Dexamethasone Doses on Persistent Postmastectomy Pain
NCT02551133
Effect of Pectoralis Block on Analgesia After Simple Mastectomy
NCT03143530
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dexmetedomedine
preoperative ultrasound guided modified Pecs block with 30 mL of 0.25% bupivacaine plus Dexmedetomidine (1 µg/kg)
Dexmedetomidine
preoperative ultrasound guided modified Pecs block with 30 mL of 0.25% bupivacaine plus Dexmedetomidine (1 µg/kg)
control
preoperative ultrasound guided modified Pecs block with 30 mL of 0.25% bupivacaine
placebo
preoperative ultrasound guided modified Pecs block with 30 mL of 0.25% bupivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
preoperative ultrasound guided modified Pecs block with 30 mL of 0.25% bupivacaine plus Dexmedetomidine (1 µg/kg)
placebo
preoperative ultrasound guided modified Pecs block with 30 mL of 0.25% bupivacaine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* weight 50- 100 kg)
Exclusion Criteria
* relevant drug allergy
* opioid dependence,
* sepsis,
* those with psychiatric illnesses
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South Egypt Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr.mohamad farouk mohamad
lecturer of anesthesia,ICU and pain relief
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mohamad F mohamad, MD
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Saher mohamad, MD
Role: STUDY_DIRECTOR
Cancer Institute, Anesthesia, Intensive Care, and Pain Management, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
222
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.